Social Experiences of Adolescents and Young Adults With Cancer
1 other identifier
observational
121
1 country
1
Brief Summary
Participants are being asked to take part in this clinical trial, a type of research study, because investigators want to learn more about the social experiences adolescents and young adults who are being treated or have been treated for cancer. Primary Objectives
- Describe differences in social experience variables (peer connectedness, perceived social competence, parent versus peer attachment) based on treatment status: on versus off therapy.
- In on-therapy patients, describe differences in social experience variables (peer connectedness, perceived social competence, parent versus peer attachment) based on developmental stage: high school versus post-high school. Secondary Objectives
- Assess the social support and peer interaction needs of AYA with cancer as a means of determining stakeholder interest and need for psychosocial interventions targeting social experiences.
- Using qualitative interviews, explore patient perceptions of the impact of cancer on social experiences among AYA, particularly with regards to changes in friendships as a result of the cancer diagnosis and the role of the hospital in helping or hindering friendship maintenance/development. Exploratory Objectives
- Explore differences in social experience by demographic, disease and treatment factors, including: gender, diagnostic category (brain tumor, leukemia/lymphoma, solid tumor), late effects/symptom burden, and treatment (e.g., treatment intensity, serious medical events).
- Explore associations between perceived impact of cancer and social experience in AYA.
- Explore associations between use of social media and social experience.
- Explore associations between social experiences and overall functioning (quality of life, distress, coping).
- Explore the possibility of subclasses of AYA by using person-centered analyses to empirically derive profiles of social experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2020
CompletedFirst Posted
Study publicly available on registry
March 31, 2020
CompletedStudy Start
First participant enrolled
October 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
April 23, 2026
April 1, 2026
6.1 years
March 27, 2020
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Inventory of Parent and Peer Attachment (IPPA).
This is a self-report measure of perceptions of the relationship between an individual and their mother, father and close friends.
Baseline
UCLA Loneliness Scale.
This 20-item self-report questionnaire assesses perceptions of peer connectedness over the past month. Items assess feelings of social connectedness, loneliness, and social isolation. Questions are answered on a 4-point Likert scale from "never" to "often," and a total score is calculated.
Baseline
Family Management Measure (FMM).
This is a 53-item measure for parents designed to assess the impact of a child's health condition on the family system. Six subscales are derived, including measures of the child's daily life, the parent's perceived ability to manage the condition, and, for partnered parents, how the parents work together to manage the condition.
Baseline
Self-Perception Profile for Adolescents/Emerging Adults (SPPA/EA).
The SPPA/EA is a self-report measure of self-competence. Multiple constructs are assessed, including social, romantic, physical, and academic competence, as well as global self-worth. Subscales assessing Social Competence, Romantic Competence and Physical Appearance are of primary interest.
Baseline
NIH Toolbox - Friendship
This is a 5- (ages 15-17) or 8-item (ages 18+) self- report questionnaire that assesses aspects of friendship. Questions assess perceived ability to access friend and participation in activities with friends over the past month on a 5-point Likert scale from never to always. Five items are similar across the two age groups. Raw scores are converted to T-scores (M = 50, SD = 10), with higher scores indicative of more perceived friends to interact with.
Baseline
Secondary Outcomes (11)
Young Adult Cancer Impact Scale
Baseline
Centrality of Events (COE).
Baseline
Online Social Support Scale (OSSS).
Baseline
Multidimensional Scale of Perceived Social Support (MSPSS).
Baseline
Responses to Stress Questionnaire (RSQ)
Baseline
- +6 more secondary outcomes
Study Arms (2)
AYA who are on treatment 2-12 months post -diagnosis
AYA will complete questionnaires assessing peer versus family connectedness, peer/romantic competence, coping, distress, social support, and quality of life.A study-specific needs assessment regarding interest in social functioning interventions will also be completed. Participants (30 on-therapy) will be interviewed to further explore aspects of peer/family connectedness and intervention interest.
AYA who are off -therapy 1 to 4 years
AYA will complete questionnaires assessing peer versus family connectedness, peer/romantic competence, coping, distress, social support, and quality of life.A study-specific needs assessment regarding interest in social functioning interventions will also be completed. Participants (20 off-therapy) will be interviewed to further explore aspects of peer/family connectedness and intervention interest.
Eligibility Criteria
All participants who meet eligibility criteria and consent to enrollment on the study.
You may qualify if:
- All Participants
- Age 15 - 22
- Primary oncology diagnosis.
- Reads and speaks English.
- On-Therapy Strata
- months from diagnosis and receiving cancer-directed therapy.
- Off-Therapy Strata
- years post-treatment, diagnosed at ≥13 years of age.
- Caregivers Reads and speaks English
- Consent received from adult participant to contact, as it applies
You may not qualify if:
- Surgery only treatment plan.
- IQ less than 70 as documented in the medical record.
- Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated with neurocognitive or social impairment (e.g., autism, Neurofibromatosis Type 1 (NF1), Down syndrome).
- Inability or unwillingness of research participant or legal - guardian/representative to give written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah W. Daniels, PhD
St. Jude Children's Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2020
First Posted
March 31, 2020
Study Start
October 12, 2020
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
April 23, 2026
Record last verified: 2026-04